Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Pragmatist on Feb 19, 2021 5:44pm

Shelf Supplement

The supplement isnow available on Sedar;  The price to the public is $6.

 "NOTES: (1) The Offering Price was determined by negotiation between the Company and the Underwriters, with reference to the then-current market price of the Common Share"


The price was likely determined before the recent escalation.  It sounds like a good deal. for ATE..

My understaning based on research last PO, is that underwriters and their officers are not allowed to participate in Canadian public  offerings , unless specifically mentioned.  So they are selling to the public via brokers. And they want to offload these as quickly as possible.  Their reward is the commission.
Comment by Hideaway on Feb 19, 2021 6:28pm
If they are selling to the public at $6 per share, does this include the warrants? If not, can one purchase the warrants seperately? Hope someone on Board can educate me and, if shares and/or warrants are avaiable how does a small investor participate?TIA.
Comment by Pragmatist on Feb 19, 2021 6:35pm
It includes the warrants.  Regarding warrant purchases separately,  this is addressed in the Supplement, and if I recall, it specifies that the warrants cannot be sold separately, such as on the open market.  I think it is too late to participate now if you have not already put an order in with your broker.
Comment by Miceberg on Feb 19, 2021 6:39pm
Warrants trade ike shares - if you can get someone willing to sell!
Comment by Pragmatist on Feb 19, 2021 6:47pm
Yes.....but not these ones ON AN EXCHANGE. "The Warrants are transferable but will not be listed for trading on any exchange and as a result, there is no market through which the Warrants may be sold and purchasers may not be able to resell the Warrants purchased under the Prospectus Supplement and the accompanying Shelf Prospectus."  
Comment by Marky1 on Feb 19, 2021 6:49pm
Pragmatist. Welcome to my club of very intelligent people....
Comment by Pragmatist on Feb 20, 2021 6:09pm
Hideaway, further to iscfa's post, it appearsfrom the supplement  that the units can boken up to sell as shares and warrants under specific circumstances, so you might be able to pick up warrants on their own. Probaly a small chance, but you  would have to talk to your broker.   "The Company has granted to the Underwriters the Over-Allotment Option exercisable, in whole ...more  
Comment by Pragmatist on Feb 19, 2021 6:31pm
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities